# A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

> **NCT06461039** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 43 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** NNC0487-0111 A
- **DRUG:** NNC0487-0111 C
- **DRUG:** Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC)
- **DRUG:** Acetaminophen - 500 mg/15 ml

## Key facts

- **NCT ID:** NCT06461039
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-14
- **Primary completion:** 2025-03-16
- **Final completion:** 2025-04-04
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461039, "A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT06461039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*